Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Maintenance of Response After Open-Label Treatment With Atomoxetine Hydrochloride in Adult Outpatients With Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdrawal Study
Atomoxetine
B4Z-MC-LYDO
NCT00700427
Attention Deficit Hyperactivity Disorder
Phase 3
 
The annotated case report form is not available. A blank case report form will be provided.
November 2014

Powered by ideaPoint, Inc.